Evidence map›Paper›PMID 28049201›Full record

Trial reportNephron2017

A Pilot Randomized Controlled Trial to Promote Immunosuppressant Adherence in Adult Kidney Transplant Recipients.

Daniel Cukor, Nisha Ver Halen, Melissa Pencille, Fasika Tedla, Moro Salifu

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nephron, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 3 pooled it
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 3 syntheses or guidelines pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Understanding Medication Nonadherence after Kidney Transplant.Journal of the American Society of Nephrology : JASN · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Daniel CukorDepartment of Psychiatry and Behavioral Science, SUNY Downstate Medical Center,Brooklyn, N.Y., USA.
Nisha Ver Halen
Melissa Pencille
Fasika Tedla
Moro Salifu
SUNY Downstate Health Sciences University · USCenter for Brooklyn History · US

Funding

RESEARCH TRAINING/EDUCATION COREP20MD006875 · NIMHD · SUNY DOWNSTATE MEDICAL CENTER · PI BROWNE, RUTH C, FRASER, MARILYN · 2012 to 2016
$5.3M
Measuring and improving medication adherence in kidney transplant patientsR03DK089149 · NIDDK · SUNY DOWNSTATE MEDICAL CENTER · PI CUKOR, DANIEL · 2010 to 2011
$158k
NIDDK NIH HHS R03 DK089149NIMHD NIH HHS P20 MD006875
6 · The paper itself

Abstract

backgroundNonadherence to immunosuppressant medication is a prevalent practice among kidney transplant recipients and has been associated with increased risk for graft failure and economic burden. The aim of this pilot study was to test whether a culturally sensitive cognitive-behavioral adherence promotion program could significantly improve medication adherence to tacrolimus prescription as measured by telephone pill counts among kidney transplant recipients.

methodsThirty-three adult transplant recipients were less than 98% adherent to tacrolimus prescription based on 3 telephone pill counts and were randomized either to the 2-session cognitive-behavioral adherence promotion program or to standard care. The curriculum was developed from an iterative process with transplant recipients into a 2-session group program that provided psychoeducation, addressed barriers to adherence, fostered motivation to improve adherence behavior, and discussed cultural messages on adherence behavior.

resultsThe intervention group displayed significantly higher levels of adherence when compared to the control group (t = 2.2, p = 0.04) and. similarly, when the amount of change was compared between the groups, the intervention group showed more change than the control condition (F (22,1) = 12.005, p = 0.003). Tacrolimus trough concentration levels were used as a secondary measure of adherence and, while there were no significant between-group differences for mean trough concentration levels, the variability in the trough levels did significantly decrease over time indicating more consistent pill-taking behavior in the intervention group.

conclusionsThere is preliminary support for the pilot program as a successful intervention in helping patients with their immunosuppressant medication.

Indexed as

Kidney TransplantationMedication AdherenceAdultAgedFemaleHumansImmunosuppressive AgentsInterviews as TopicMaleMiddle AgedPilot ProjectsTacrolimusTransplant RecipientsImmunosuppressive AgentsTacrolimus

Identifiers

PMID28049201
PMCPMC5215864
OpenAlexW2515116142

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.